SOLIGENIX, INC. Current Liabilities
SOLIGENIX, INC. (SNGX) had Current Liabilities of $3.67 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Liabilities, Current $3.67M.
- 2026-03-31: Liabilities, Current $3.62M.
- 2025-12-31: Liabilities, Current $3.70M.
- 2025-09-30: Liabilities, Current $3.42M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $3.67M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $3.62M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $3.70M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $3.42M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $3.63M 10-Q · filed 2025-08-14 |
| 2024-12-31 | $4.85M 10-K · filed 2026-03-31 |
| 2024-09-30 | $4.53M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $6.35M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $7.21M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $6.15M 10-K · filed 2025-03-21 |
| 2023-09-30 | $5.52M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $5.76M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $11.38M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $16.52M 10-K · filed 2024-03-15 |
| 2022-09-30 | $9.67M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $8.84M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $7.22M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $6.29M 10-K · filed 2023-03-31 |
| 2021-09-30 | $4.80M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $4.12M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $4.30M 10-Q · filed 2021-05-18 |
| 2020-12-31 | $6.08M 10-K · filed 2022-03-29 |
| 2020-09-30 | $5.54M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $6.00M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $6.33M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $6.31M 10-K · filed 2021-03-30 |
| 2019-09-30 | $5.63M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.50M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $4.15M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $4.21M 10-K · filed 2020-03-30 |
| 2018-09-30 | $4.02M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $3.53M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $3.41M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $3.23M 10-K · filed 2019-03-26 |
| 2017-09-30 | $2.71M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $3.15M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $2.59M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $2.87M 10-K · filed 2018-03-15 |
| 2016-09-30 | $5.58M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $5.38M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $6.64M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $7.41M 10-K · filed 2017-03-27 |
| 2015-09-30 | $6.82M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $8.89M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $7.73M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $7.11M 10-K · filed 2016-03-24 |
| 2014-09-30 | $10.55M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $10.81M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $11.12M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $10.04M 10-K · filed 2015-03-25 |
| 2013-09-30 | $11.25M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $6.82M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $1.68M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $1.15M 10-K · filed 2014-03-26 |
| 2012-09-30 | $1.05M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $1.29M 10-Q · filed 2012-08-10 |
| 2012-03-31 | $1.35M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $1.43M 10-K · filed 2013-02-26 |
| 2011-09-30 | $1.41M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $1.42M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $1.91M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |